India signed contract for microlight aircrafts with Slovenian firm Pipistrel

Oct 13, 2015 10:14 IST

India on 12 October 2015 signed a deal, worth 105.5 crore rupees, with Pipistrel, a Slovenian firm, for 194 micro-light aircraft to be used by Indian Air Force, the Navy and the National Cadet Corps (NCC).

The contract has been signed with the firm for Virus SW 80/100. However, the Indian version of the aircraft will be renamed as Garud.

The deal is signed after four years of protracted negotiations with the Slovenian firm meeting all the requirements put forth by India.

As per the deal, the entire quantity of 194 aircrafts must be delivered within 30 months from the day of the first delivery.

The contract incorporates an option for an additional 100 aircrafts within the third year if the buyer requests them.

It was in 2011 that India issued a Request for Proposal (RfP) for the micro-light aircrafts.

About Pipistrel Virus

• It is a two-seater light aircraft manufactured in Slovenia and sold as an ultralight, homebuilt kit, or light-sport aircraft.

• It is a high-wing, cantilever monoplane of pod-and-boom configuration with a T-tail.

• It won the NASA 2007 Personal Air Vehicle (PAV) Challenge and the 2008 General Aviation Technology (GAT) Challenge.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

Is this article important for exams ? Yes9 People Agreed
Read more Current Affairs on: Pipistrel Virus , Garud , Pipistrel , Slovenia , Microlight aircrafts , IAF , Navy , NCC

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK